0001140361-23-034436.txt : 20230713 0001140361-23-034436.hdr.sgml : 20230713 20230713161822 ACCESSION NUMBER: 0001140361-23-034436 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20230713 DATE AS OF CHANGE: 20230713 EFFECTIVENESS DATE: 20230713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: METLIFE INC CENTRAL INDEX KEY: 0001099219 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 134075851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-18621 FILM NUMBER: 231086962 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-578-5500 MAIL ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 13F-HR/A 1 primary_doc.xml X0202 13F-HR/A LIVE 0001099219 XXXXXXXX 03-31-2019 03-31-2019 true 3 NEW HOLDINGS METLIFE INC
200 PARK AVENUE NEW YORK NY 10166
13F COMBINATION REPORT 028-18621 0000931588 028-16107 Provida Pension Fund Administrator 0000728618 028-00491 Metropolitan Life Insurance Co/NY 0001529735 028-18628 000142463 801-67314 MetLife Investment Management, LLC Y This amendment adds new holdings entries of securities that were inadvertently omitted in the 13F Combination Report filed for this quarter, as amended by the 13F amendments filed on March 23, 2023 and July 13, 2023. MetLife, Inc. is the parent holding company of certain institutional investment managers. For purposes of the reporting requirements under Section 13(f) of the Securities Exchange Act of 1934 (the Act), and the rules promulgated thereunder, MetLife, Inc. itself does not exercise, and therefore disclaims, investment discretion with respect to any Section 13(f) securities positions over which its investment operating subsidiaries exercise such discretion. To the extent, however, that MetLife Inc.'s ownership interest in such subsidiaries may nevertheless give rise to a Form 13F obligation on behalf of MetLife, Inc., the information required by Form 13F is reported herein on behalf of all such subsidiaries.
Steven Goulart EVP & Chief Investment Officer 973-355-4814 /s/ Steven Goulart WHIPPANY NJ 07-13-2023 0 2 18094570
INFORMATION TABLE 2 informationtable.xml ISHARES INC MSCI CHILE ETF 464286640 4537469 105107 SH DFND 0 105107 0 CELLCOM ISRAEL LTD SHS M2196U109 13557101 196385 SH DFND 0 196385 0